P. Hausner

发表

Case report of capecitabine toxicity and use of uridine triacetate

A. Duffy, Wesley D. Oliver, P. Hausner, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival.

M. Suntharalingam, M. Edelman, L. Doyle, 2005, The Journal of thoracic and cardiovascular surgery.

Phase II trial of gemcitabine/carboplatin followed by paclitaxel in patients with performance status=2,3 or other significant co-morbidity (HIV infection or s/p organ transplantation) in advanced non-small cell lung cancer.

M. Edelman, L. Doyle, J. Brahmer, 2008, Lung cancer.

Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation.

M. Edelman, S. Feigenberg, J. Feliciano, 2013, Molecular and cellular pharmacology.

Immunoglobulin/Myc recombinations in Murine Peyer's patch follicles

Joy A. Williams, P. Hausner, J. Müller, 1997, Genes, chromosomes & cancer.

Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature.

J. Basile, J. Brooks, P. Hausner, 2019, Journal of immunotherapy.

Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation.

M. Suntharalingam, M. Edelman, L. Doyle, 2010, The Annals of thoracic surgery.

Treatment of melanoma with wild-type p53 (wtp53) and detectable S100B using pentamidine: A phase II trial with correlative biomarker endpoints.

David J Weber, E. Sausville, M. Tan, 2010 .

Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association

J. Litzman, I. Vořechovský, P. Hausner, 2005, Cancer Immunology, Immunotherapy.

Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres

N. Bhooshan, M. Guerrero, B. Yi, 2018, Nuclear medicine communications.

Characterization of C57BL/6 plasmacytomas lacking a c‐myc translocation

S. Rudikoff, J. Pumphrey, P. Hausner, 1997, International journal of cancer.

Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.

W. Regine, Anshum Sood, K. Miller, 2020, Journal of wound care.

The Thy-1 glycoprotein is expressed in mouse embryonal carcinoma cells P19.

P. Malý, P. Dráber, P. Hausner, 1989, The International journal of developmental biology.

Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors.

P. Soballe, K. Nakahara, I. Kirsch, 1997, Cancer research.

Outcomes After Trimodality Therapy for Esophageal Cancer: The Impact of Histology on Failure Patterns

M. Suntharalingam, M. Krasna, M. Koshy, 2011, American journal of clinical oncology.

Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer.

M. Edelman, L. Doyle, J. Kendall, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MACROPHAGE ELECTROPHORETIC MOBILITY TEST AS A SENSITIVE PROBE OF TRANSPLANTATION IMMUNITY IN MICE

M. Boubelík, J. Bubeník, M. Malkovský, 1979, Transplantation.

The "comparative growth assay": examining the interplay of anti-cancer agents with cells carrying single gene alterations.

D. Venzon, I. Kirsch, P. Hausner, 1999, Neoplasia.

Image-guided thermal ablation of tumor increases the plasma level of interleukin-6 and interleukin-10: is plasma level of interleukin-6 a surrogate for immunogenic cell death?

P. Hausner, 2013, Journal of vascular and interventional radiology : JVIR.

Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer.

M. Suntharalingam, M. Edelman, L. Doyle, 2008, The Annals of thoracic surgery.

BRAF-driven pancreatic cancer: prevalence, molecular features and therapeutic opportunities.

P. Hausner, Yixing Jiang, Aaron T. Ciner, 2022, Molecular cancer research : MCR.

review Current treatment options and biology of peritoneal mesothelioma: meeting summary of the ﬁrst NIH peritoneal mesothelioma conference

M. Metintaş, P. Boffetta, V. Roggli, 2006 .

Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).

M. Vosecký, I. Hilgert, V. Hořejší, 1988, Folia biologica.

Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.

V. Israel, D. Gandara, M. Edelman, 2003, Lung cancer.

Testis: A sanctuary site in merkel cell carcinoma

W. Mcguire, M. Tummala, P. Hausner, 2006 .

Radiation in the management of pancreatic neuroendocrine tumors.

M. Choti, J. Cameron, R. Hruban, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.

S. Rudikoff, J. Pumphrey, V. Roschke, 1998, Cancer research.

Phase I study of docetaxel and topotecan in patients with solid tumors

M. Edelman, L. Doyle, M. Egorin, 2000, Cancer Chemotherapy and Pharmacology.

Abstract 3183: Initial safety of AFP SPEAR T-cells in patients with advanced hepatocellular carcinoma

J. Bruix, R. Finn, A. El-Khoueiry, 2019, Immunology.

CASE 1. Testis: a sanctuary site in Merkel cell carcinoma.

W. Mcguire, M. Tummala, P. Hausner, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.